• OPEN AN ACCOUNT
Indian Indices
Nifty
25,114.00 108.50
(0.43%)
Sensex
81,904.70 355.97
( 0.44%)
Bank Nifty
54,809.30 139.70
( 0.26%)
Nifty IT
36,110.75 107.30
( 0.30%)
Global Indices
Nasdaq
45,857.35 271.66
(-0.59%)
Dow Jones
6,605.38 -3.09
(-0.05%)
Hang Seng
44,778.02 405.52
(0.91%)
Nikkei 225
9,283.29 -14.29
(-0.15%)
Forex
USD-INR
88.28 0.18
(0.20%)
EUR-INR
103.39 0.27
(0.26%)
GBP-INR
119.55 0.32
(0.27%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

GHV Infra Projects Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
505504
INE809Q01012
29.5352064
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
102.82
2255.88
EPS(TTM)
Face Value()
Div & Yield %
15.22
10
0
 

As on: Sep 12, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,130.70 3.70 7973 32.09
Stock Price Details
Open Price() 2,149.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,156.75
Today's Low () 2,118.95
52-Week High () 2286.15
152-Week Low () 1274.7
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.12
Eps 66.4
Book Value 868.316327
Market Cap (.Cr) 60,128.53
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE935A01035


News
Ichnos Glenmark Innovation receives upfront payment of USD700 million
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharma initiates Phase 3 clinical trial for Envafolimab
Glenmark Pharma’s US arm to launch Eribulin Mesylate injection in the US market
Glenmark USA to launch Eribulin Mesylate Injection, mg/2 mL (0.5 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Copy of Newspaper Publication
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Shareholders meeting
More
Corporate Details
Incoporation Year   : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • BSE Shariah 50
  • MIDCAP 200
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi